Interne link ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC september 27, 2016 om 11:00 AM UTC
Interne link ProQR to Present at Scientific and Investor Conferences in September september 06, 2016 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2016 augustus 17, 2016 om 11:00 AM UTC
Interne link ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis juli 19, 2016 om 11:00 AM UTC
Interne link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC juni 21, 2016 om 01:00 PM UTC
Interne link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-110 for LCA10 at the 2016 ARVO Annual Meeting april 25, 2016 om 08:00 PM UTC
Interne link ProQR to Highlight a Growing Pipeline During a Research & Development Day and Present at the Barclays Global Healthcare Conference maart 01, 2016 om 12:00 PM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2015 februari 17, 2016 om 12:00 PM UTC
Interne link ProQR to Present at the Leerink Partners Global Healthcare Conference februari 03, 2016 om 12:00 PM UTC
Interne link ProQR Announces R&D Day and Provides Update on Innovation Portfolio november 30, 2015 om 12:00 PM UTC
Interne link ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials november 23, 2015 om 11:30 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences oktober 01, 2015 om 11:00 AM UTC
Interne link ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable september 23, 2015 om 11:00 AM UTC
Interne link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment september 14, 2015 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2015 augustus 19, 2015 om 11:59 AM UTC
Interne link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients juni 26, 2015 om 11:54 AM UTC
Interne link ProQR to Present at the JMP Securities Life Science Conference juni 16, 2015 om 11:00 AM UTC
Interne link ProQR Therapeutics Announces Results for the First Quarter of 2015 mei 21, 2015 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in May april 29, 2015 om 11:00 AM UTC
Interne link ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 februari 26, 2015 om 12:00 PM UTC